Surgery – Means for introducing or removing material from body for... – With means for cutting – scarifying – or vibrating tissue
Reexamination Certificate
1999-08-16
2003-07-01
Nguyen, Anhtuan T. (Department: 3763)
Surgery
Means for introducing or removing material from body for...
With means for cutting, scarifying, or vibrating tissue
Reexamination Certificate
active
06585678
ABSTRACT:
FIELD OF THE INVENTION
This invention relates to a booster useful for enhancing the effects of ultrasound in the therapy of various diseases and a pharmaceutical liquid composition containing the booster and a medicament which shows enhanced diffusion and penetration of the medicament into the body by applying ultrasound. More particularly, it relates to a booster useful for therapy of various disease by applying ultrasound which comprises a plurality of microbubbles of a gas in a liquid, a pharmaceutical liquid composition comprising a plurality of microbubbles of a gas and a medicament in a liquid, and the user thereof in the therapy of various diseases while applying ultrasound.
PRIOR ART
It is known that various diseases are remedied by the aid of ultrasonic vibration. For example, it is described in Japanese Patent First Publication (Kokai) No. 115591/1977, etc. that percutaneous absorption of a medicament is enhanced by applying an ultrasonic vibration. Japanese Patent First Publication (Kokai) No. 180275/1990 discloses a drug-injecting device which is effective on the diffusion and penetration of the drug by applying an ultrasonic vibration in the step of injecting a drug into a human body via a catheter or a drug-injecting tube. U.S. Pat. Nos. 4,953,565 and 5,007,438 also disclose the technique of percutaneous absorption of medicaments by the aid of ultrasonic vibration. It is also reported that a tumor can be remedied by concentratedly applying ultrasound from outside the body.
In order to enhance the therapeutic effects with ultrasound, it is required to apply a high energy ultrasonic vibration. However, ultrasonic vibration at an energy that is too high causes disadvantageously burns or unnecessary heat at the portion other than the desired portion. On the other hand, when the energy of an ultrasonic vibration is lowered for eliminating such disadvantages, there is a problem of less effect of the ultrasound at the desired portion.
SUMMARY OF THE INVENTION
The present inventors have intensively studied enhancing the effects of ultrasound at a lower energy of an ultrasonic vibration and have found that a booster comprising a plurality of microbubbles of a gas in a liquid is useful for the desired enhancement of the effects of ultrasound.
An object of the invention is to provide a booster useful for enhancing the effects of ultrasound which comprises a plurality of microbubbles of a gas in a liquid. Another object of the invention is to provide a pharmaceutical liquid composition containing the booster and a medicament which is useful for the therapy of various diseases together with the application of ultrasound. A further object of the invention is to provide a method for enhancing the effects by the application of ultrasound in the therapy of various diseases which comprises injecting the booster or the pharmaceutical liquid composition as set forth above into the portion to be remedied while applying ultrasound thereto. These and other objects and advantages of the invention will be apparent to those skilled in the art from the following description.
REFERENCES:
patent: 2961382 (1960-11-01), Singher et al.
patent: 4466442 (1984-08-01), Hilmann et al.
patent: 4657756 (1987-04-01), Rasor et al.
patent: 4762915 (1988-08-01), Kung et al.
patent: 4774958 (1988-10-01), Feinstein
patent: 4797285 (1989-01-01), Barenholz et al.
patent: 4844882 (1989-07-01), Widder et al.
patent: 4900540 (1990-02-01), Ryan et al.
patent: 4936281 (1990-06-01), Stasz
patent: 5040537 (1991-08-01), Katakura
patent: 5069664 (1991-12-01), Guess et al.
patent: 5088499 (1992-02-01), Unger
patent: 5156050 (1992-10-01), Schmid et al.
patent: 5158071 (1992-10-01), Umemura et al.
patent: 5197946 (1993-03-01), Tachibana
patent: 5209720 (1993-05-01), Unger
patent: 5215680 (1993-06-01), D'Arrigo
patent: 5216130 (1993-06-01), Line et al.
patent: 5269291 (1993-12-01), Carter
patent: 5362309 (1994-11-01), Carter
patent: 5431663 (1995-07-01), Carter
patent: 5836896 (1998-11-01), Rosenschein
patent: 5997497 (1999-12-01), Nita et al.
patent: 634470 (1993-02-01), None
patent: 0 224 934 (1987-06-01), None
patent: 0 278 074 (1988-08-01), None
patent: 0 327 490 (1989-08-01), None
patent: 15 77551 (1980-10-01), None
patent: 52115591 (1977-09-01), None
patent: 02-180275 (1990-07-01), None
patent: WO 89/05159 (1989-06-01), None
patent: WO 89/05160 (1989-06-01), None
patent: WO 90/01971 (1990-03-01), None
patent: WO 80/01365 (1990-11-01), None
Meltzer et al, J Clin Ultrasound 8(2); 121-7 (Apr. 1980) The Source of Ultrasound Contrast Effect*.
Keller et al, J. Ultrasound Med. 5(9): 493-8 (Sep. 1986) Automated Production and Analysis of Echo Contrast Agents*.
Leong et al, Biomaterials 7: 364-371 (Sep. 1986) Polyanhydrides for Controlled Release of Bioactive Agents*.
B.D. Butler, J Clin. Ultrasound 14(5): 408-12 (Jun. 1986) Production of Microbubbles for Use as Echo Contrast Agents*.
Feinstein et al, J Am. Coll.Cardiol. 3(1): 14-20 (Jan. 1984) Two-dimensional Contrast Echocardiography I. In Vitro Development and Quantitative Analysis of Echo Contrast Agents*.
Lang et al, Circulation 75(1): 229-234 (Jan. 1987) Contrast Ultrasonography of the Kidney: a New Method for Evaluation of Renal Perfusion in Vivo*.
Vandenburg et al, Am. Heart.J. 115(4): 733-9 (Apr. 1988) Myocardial Risk Area and Peak Gray Level Measurement by Contrast Echocardiography: Effect of Microbubble Size and Concentration, Injection Rate, and Coronary Vasodilation*.
T.F. Kim, Medical News & Perspectives, JAMA 261 (11): 1542 (Mar. 17, 1989) Microbubbles Show Promise for Enhancing Ultrasound Signal, Image, Other Applications*.
C.K. Holland and R.E. Apfel, J. Acoust.Soc.Am. 88(5): 2059-2069 (Nov. 1990) Thresholds for Transient Cavitation Produced by Pulsed Ultrasound in a Controlled Nuclei Environment*.
Wheatley et al, Biomaterials 11(19): 713-7 (Nov. 1990) Contrast Agents for Diagnostic Ultrasound: Development and Evaluation of Polymer-Coated Microbubbles*.
Bleeker et al. J. Ultrasound Med. 9(8): 461-71 (Aug. 1990) On the Application of Ultrasonic Contrast Agents for Blood Flowmetry and Assessment of Cardiac Perfusion*.
Tachibana Katsuro
Tachibana Shunro
Ekos Corporation
Knobbe Martens Olson & Bear LLP
Nguyen Anhtuan T.
LandOfFree
Booster for therapy of disease with ultrasound and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Booster for therapy of disease with ultrasound and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Booster for therapy of disease with ultrasound and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3051752